The cytoplasmic Nrf2 proteins were increased by 2.0- and 2.4- fold in tumors at 24 h and 48 h, respectively, after a single dose of 10 mg/kg RRx-001 compared to control tumor without RRx-001 treatment. The gene discussed is NFE2L2; the disease is neoplasm.